(R)-6-(4-Aminophenyl)-5-Methyl-4,5-Dihydropyridazin-3(2H)-One (R)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮
CAS 101328-85-2 MFCD09032921
化学结构图
SMILES: CC1CC(=O)NN=C1C1C=CC(N)=CC=1
化学属性
| Mol. Formula | C11H13N3O |
|---|---|
| Mol. Weight | 203.244 |
别名和识别编码
| Chemical Name | (R)-6-(4-Aminophenyl)-5-Methyl-4,5-Dihydropyridazin-3(2H)-One |
|---|---|
| Chemical Name Translation | (R)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2H)-哒嗪酮 |
| InChIKey | GDMRFHZLKNYRRO-SSDOTTSWSA-N |
| LabNetwork Molecule ID | LN01281785 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Mark P. Hehir, et al. 487: OR-1855, a levosimendan metabolite with an effect on human myometrial contractility.December 2009Volume 201, Issue 6, Supplement, Pages S182-S183.
- [1]. Banfor PN, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H238-48.
- [1]. Banfor PN, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H238-48.
- [2]. Mark P. Hehir, et al. 487: OR-1855, a levosimendan metabolite with an effect on human myometrial contractility.December 2009Volume 201, Issue 6, Supplement, Pages S182-S183.
